Response to multiple glucose-lowering agents in a sib-pair with a novel HNF1α (MODY3) variant. [electronic resource]
Producer: 20210430Description: 518-520 p. digitalISSN:- 1476-5438
- Adult
- Diabetes Mellitus, Type 2 -- drug therapy
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Hepatocyte Nuclear Factor 1-alpha -- genetics
- Humans
- Hypoglycemic Agents -- therapeutic use
- Incretins -- therapeutic use
- Male
- Mutation
- Pedigree
- Pharmacogenomic Variants
- Sulfonylurea Compounds -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.